mirvetuximab
ImmunoGen
['ovarian', 'mirvetuximab', 'gyn']
mirvetuximab soravtansine demonstrated an overall survival benefit in fr -high, platinum-resistant ovarian cancer vs investigator's choice chemotherapy. #asco23 #oncology #nursing #ovariancancer #gyncsm 
Capturing the voice of nursing professionals in the oncology news landscape.